Miriam Fogelson

Miriam Fogelson has a significant work experience in the field of pharmacovigilance and drug safety. Miriam has worked at MacroGenics, Inc. from 2015 to the present, initially starting as an Associate Director and progressing to Director, and then Senior Director. Miriam'sroles have involved providing leadership and oversight in the operational aspects of drug safety, driving policy and strategy, implementing processes, and ensuring compliance with global regulations. Prior to MacroGenics, Inc., they worked at KAI Research, Inc. from 1996 to 2015, where they served as Director of Medical Affairs, managing clinical trial safety and pharmacovigilance, and establishing procedures and guidelines in accordance with regulatory standards. Miriam also worked as a Project Manager, overseeing the development of study materials and ensuring protocol compliance.

Miriam Fogelson obtained their Bachelor's degree in Medical Technology from Michigan State University from 1981 to 1985. Miriam then pursued further education and completed their Master's Degree in Health Administration at the University of Maryland between 1988 and 1992.